Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

Research Partnership is expanding its US capabilities with new offices opening in San Francisco and New York

May 2, 2017 | Expansion, New York, San Francisco, USA 

Research Partnership is today expanding its US operations across both the West and East Coast. Director Tom Winter has relocated from London and is today opening a new office in San Francisco, to better service West Coast clients.

Research Partnership is today expanding its US operations across both the West and East Coast. Director Tom Winter has relocated from London and is today opening a new office in San Francisco, to better service West Coast clients. 

Director Rachel Howard is opening a new office in New York to continue to build our emerging markets business and to provide a US hub for our syndicated business. Both Directors will manage a team of researchers and are actively recruiting for additional staff at each of these sites. The two new offices, and the regional office in Boston, complement the company’s US Headquarters in Philadelphia which is led by President Harriet Kozak.  

Tom Winter is supported by Associate Director Birgit Eschmann and Research Manager Will Simpson. Michelle Toennies, Senior Research Executive and Rebecca D’Orazio, Research Executive are both relocating from the Philadelphia office. In addition, two local graduates will be joining the team in June.   

Rachel is supported by Fara Mboge, Head of Business Development, Syndicated and Tracking services and Alyssa Pritchard, Senior Research Executive. Two local graduates will also be joining the New York team in June.  

Commenting on the expansion, Mary Assimakopoulos, Founding Director, said, “Research Partnership is celebrating its 20th anniversary this year. We have become one of the largest independent global healthcare market research agencies and our further expansion in the US is in line with our key objective for achieving continued growth in this key market.”

Visit researchpartnership.com to find out more.

This content was provided by Inizio

Company Details

- PMLiVE

Inizio

Email
Website

 Latest Content from  Inizio 

Intelligent field team engagement: Turning shared knowledge into deeper insights and better decisions.

At Age of AI 2026, Inizio Medical’s Phil Wakefield and Inizio Ignite’s Tim Luxford will explore how cross-functional collaboration and AI can unlock faster, more actionable insights across medical and...

AI in practice: 4 real-world use cases in health and life sciences

Artificial Intelligence (AI) is often discussed in broad terms, with promises of transformation at scale. In practice, however, its value is realized in far more specific ways – when it...

How will AI change field training?

Learn how a next-generation approach to field training – powered by GenAI and avatar simulations and enabled through Intelligent Commercialization™ – can transform field force effectiveness by delivering scalable, always-on,...

Inizio Ignite Sparks a New Era of Connected Advisory Solutions

Inizio, a leading global commercialization partner for pharma and life sciences, today unveiled Inizio Ignite, a reimagined, fully integrated advisory partner designed to accelerate pharma performance through strategy, insights, and innovation.

MM+M Podcast explores AI-powered audience intelligence with Inizio Evoke

The MM+M Podcast features a conversation with Jamie Avallone, Chief Data Officer at Inizio Evoke, and Iris Lin, Product Science Lead at Inizio Evoke, who share their perspectives on what...

Inizio Engage CEO Jim Sage featured in pharmaphorum’s “12 Questions” series

Discover Jim Sage’s insights on leadership, industry challenges, and the transformative impact of data, technology, and patient-centric innovation in his latest pharmaphorum “12 Questions” interview.

Reframing the Obesity Conversation: Key Takeaways from ObesityWeek® 2025

As the understanding of obesity continues to evolve, so too does the science, patient experience, and cross-sector collaboration driving innovation. At ObesityWeek® 2025 in Atlanta, experts from across Inizio reflected...

How DataGateway unified oncology data for real-world insights & market intelligence

Discover how our DataGateway platform unifies fragmented real-world oncology data into a single, validated dataset that delivers deeper insights and faster decision-making.

Inizio launches InConcert™ to transform pre-launch planning through connected intelligence.

Inizio today announced the launch of InConcert™, a new AI-powered data solution designed to accelerate smarter, evidence-led decisions during the critical pre-launch phase of the product lifecycle.

ESMO 2025 highlights: How storytelling, design & emotion are transforming scientific engagement

Discover key insights from ESMO 2025 on how design, emotion, and sustainability are reshaping medical congress experiences. Featuring expert takes from Inizio leaders.